超越复发:重新定义心房的负担作为预后和治疗终点
Andrea Ballatore1,2, Carola Griffith Brookles1,2, Mark O'Neill3,4
1Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza Hospital, Turin, Italy.
Heart (British Cardiac Society)
|October 7, 2025
概括
前庭动 (AF) 负担,即心律失常所花费时间的百分比,比传统方法更准确地衡量治疗成功率. 需要进一步的研究来规范其定义和在临床实践中的应用.
科学领域:
- 心脏病学 心脏病学
- 医疗技术 医疗技术 医学技术
背景情况:
- 传统的心房动 (AF) 根据发作持续时间和二进制复发评估 (例如,>30s) 的分类有局限性.
- 目前的方法可能不能准确地反映心律失常的时间,或者与诸如导管切除 (CA) 等干预后的临床结果有很好的相关性.
研究的目的:
- 审查心房的负担的影响和预后价值.
- 突出挑战,包括缺乏关于其临床用途的标准化定义和共识.
- 探索先进监控策略的作用,包括可穿戴设备和人工智能.
主要方法:
- 文献综述总结了关于AF负担的当前知识.
- 讨论关于AF负担临床相关性的新出现的证据.
- 探索未来的监控技术.
主要成果:
- AF负担,定义为心律失常时间的百分比,在反映CA结果和预测某些患者群体的预后方面表现有前途.
- 现有的定义不一致,需要标准化.
- 持续监控策略至关重要,这些策略可能会被可穿戴设备和人工智能增强.
结论:
- 与传统指标相比,AF负担可以提供更精确的AF管理评估.
- 标准化AF负担定义和将其纳入临床实践是必不可少的.
- 监控技术的进步具有改善AF管理的巨大潜力.
相关概念视频
Aortic Regurgitation III: Medical Management
396
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
396
Endocarditis III: Medical Management
212
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
212
Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Heart Failure IV: Classification and Diagnostic Evaluation
319
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
319
Heart Failure VI: Adjunct Therapies
255
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
255


